Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.54 USD | -0.12% | +9.69% | +55.10% |
May. 02 | Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss | MT |
May. 02 | Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Business Summary
Number of employees: 385
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicines for Cellular Metabolism
100.0
%
| 14 | 100.0 % | 27 | 100.0 % | +88.36% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 14 | 100.0 % | 27 | 100.0 % | +88.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Goff
CEO | Chief Executive Officer | 55 | 22-08-07 |
Cecilia Jones
DFI | Director of Finance/CFO | 49 | 22-09-25 |
Jacqualyn Fouse
CHM | Chairman | 62 | 17-12-04 |
Sarah Gheuens
CTO | Chief Tech/Sci/R&D Officer | 45 | 19-11-30 |
Clive Patience
CTO | Chief Tech/Sci/R&D Officer | 60 | 17-05-31 |
Investor Relations Contact | - | - | |
Charlie Newman
PRN | Corporate Officer/Principal | - | 21-12-31 |
Ellen Lopresti
HRO | Human Resources Officer | - | 16-12-31 |
T. Washburn
AUD | Comptroller/Controller/Auditor | 43 | - |
Tsveta Milanova
PRN | Corporate Officer/Principal | 47 | 23-01-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Capello
BRD | Director/Board Member | 69 | 23-05-31 |
Director/Board Member | 64 | 14-12-08 | |
May Kin Ho
BRD | Director/Board Member | 71 | 15-06-22 |
Jacqualyn Fouse
CHM | Chairman | 62 | 17-12-04 |
David Scadden
BRD | Director/Board Member | 71 | 17-05-26 |
Brian Goff
CEO | Chief Executive Officer | 55 | 22-08-07 |
Cynthia Smith
BRD | Director/Board Member | 55 | 22-08-10 |
Rahul Ballal
BRD | Director/Board Member | 46 | 22-08-10 |
Catherine Owen
BRD | Director/Board Member | - | 23-06-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 72,989,377 | 55,944,826 ( 76.65 %) | 16,216,411 ( 22.22 %) | 76.65 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.10% | 1.96B | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |
- Stock Market
- Equities
- AGIO Stock
- Company Agios Pharmaceuticals, Inc.